NCT03535701View on ClinicalTrials.gov

Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 20, 2017

Primary Completion Date

March 1, 2020

Study Completion Date

May 1, 2020

Conditions
Stage IV Breast Cancer AJCC v6 and v7
Interventions
DIETARY_SUPPLEMENT

Dietary Intervention

Undergo ketogenic diet

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Paclitaxel

Given standard of care therapy with paclitaxel

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT03535701 - Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer | Biotech Hunter | Biotech Hunter